PreDxion Bio Inc. is an American medical diagnostics company based in San Francisco, California.
PreDxion Bio was founded in February 2016 by Caroline Landau, Tim Cornell and Walker McHugh, all students at the University of Michigan.[1][2]
In June 2016, the company received its first pair of grants from the University of Michigan and MedTech Innovator.[3]
In 2018, the company received $224,944 in funding from the National Institutes of Health's Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) small business grant program.[4]
Investments and other funding has come from:[1:1][5][6]
PreDxion Bio - Crunchbase Company Profile & Funding. Crunchbase. Retrieved April 7, 2023, from https://www.crunchbase.com/organization/predxion-bio ↩︎ ↩︎
PreDxion Bio | Made at Michigan. University of Michigan. Retrieved April 7, 2023, from http://archive.today/2023.04.07-015236/https://madeatmichigan.umich.edu/ventures/venture/predxion/ ↩︎
Grant - PreDxion Bio - 2016-06-09 - Crunchbase Funding Round Profile. Crunchbase. Retrieved April 7, 2023, from https://www.crunchbase.com/funding_round/predxion-bio-grant--29259f06 ↩︎
PREDXION BIO, INC. awards summary for Fiscal Year 2018. (2018, December 31). National Institutes of Health. http://archive.today/2023.04.07-021834/https://report.nih.gov/award/index.cfm?ot=&fy=2018&state=&ic=&fm=SB&orgid=10044814&distr=&rfa=&om=n&pid=%23tab2 ↩︎
Home. PreDxion Bio. Retrieved August 28, 2021, from https://web.archive.org/web/20210828153556/https://www.predxionbio.com/ ↩︎
About Refractal - Health/Medical company in United States. F6S. Retrieved April 7, 2023, from https://www.f6s.com/company/refractal#about ↩︎